New: Introducing the Finviz Futures Map

Rein Therapeutics

Contributing Author

Recent Articles by Rein Therapeutics

Aug-19	Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis RNTX GlobeNewswire
Aug-14	Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025 RNTX GlobeNewswire
Jul-30	Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing RNTX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information